Geron Is Shutting Down Its Stem Cell Clinical Trial

The company conducting the world’s first clinical trial of a therapy using human embryonic stem cells said on Monday that it was halting that trial and leaving the stem cell business entirely. The company, Geron, said that its move did not reflect a lack of promise for the controversial field. Rather, it said, with money scarce, it…